CSB 2.012 Note(hm) Oxazepam
CSB 2.012 Note(2) Addition of the thiophene analog of phencyclidine to schedule I. Paragraph (u) of sub. (4), s. 161.14, Stats., schedule I is hereby created to read: CSB 2.012 Note(u) Thiophene analog of phencyclidine
CSB 2.012 Note(3) Addition of mecloqualone to schedule I. Subsection (5) and par. (a) of s. 161.14, Stats., schedule I are hereby created to read: CSB 2.012 Note(5) Depressants. Unless specifically excepted or unless listed in another schedule, any material compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
CSB 2.012 Note(a) Mecloqualone
CSB 2.012 Note(4) Addition of difenoxin to schedule I. Paragraph (hg) of sub. (2), s. 161.14, Stats., schedule I is hereby created to read: CSB 2.012 Note(hg) Difenoxin
CSB 2.012 Note(5) Addition of 2,5 dimethoxyamphetamine, 4-romo-2,5 dimethoxyamphetamine and 4-methoxyamphetamine to schedule I. Paragraphs (v), (w) and (x) of sub. (4), s. 161.14, Stats., schedule I are hereby created to read: CSB 2.012 Note(v) 2,5-dimethoxyamphetamine
CSB 2.012 Note(w) 4-bromo-2,5-dimethoxyamphetamine
CSB 2.012 Note(x) 4-methoxyamphetamine
CSB 2.012 HistoryHistory: Cr. Register, April, 1976, No. 244, eff. 5-1-76. CSB 2.012 NoteCSB 2.10 Addition of propiram to schedule I. Paragraph (wn) of sub. (2), s. 161.14, Stats., schedule I is hereby created to read: CSB 2.012 Note(wn) Propiram
CSB 2.012 HistoryHistory: Cr. Register, August, 1976, No. 248, eff. 9-1-76. CSB 2.012 NoteCSB 2.11 Renumbering and addition to schedule IV of diethylpropion and phentermine. Paragraph (a) of sub. (2m), s. 161.20, Stats., schedule IV is hereby renumbered to read:
CSB 2.012 Note(b) Fenfluramine
CSB 2.012 NoteParagraph (a) of sub. (2m), s. 161.20, Stats., schedule IV is hereby created to read: CSB 2.012 Note(a) Diethylpropion
CSB 2.012 NoteParagraph (b) of sub. (2m), s. 161.20, Stats., schedule IV is hereby renumbered to read:
CSB 2.012 Note(c) Pemoline
CSB 2.012 NoteParagraph (d) of sub. (2m), s. 161.20, Stats., schedule IV is hereby created to read: CSB 2.012 Note(d) Phentermine
CSB 2.012 HistoryHistory: Cr. Register, August, 1976, No. 248, eff. 9-1-76. CSB 2.012 NoteCSB 2.13 Addition of dextropropoxyphene to schedule IV. Subsection (4), s. 161.20, Stats., schedule IV is hereby created to read: CSB 2.012 Note(4) Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:
CSB 2.012 Note(a) Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane)
CSB 2.012 HistoryHistory: Cr. Register, November, 1977, No. 263, eff. 12-1-77. CSB 2.012 NoteCSB 2.14 Addition of prazepam to schedule IV. Paragraph (km), sub. (2), s. 161.20, Stats., schedule IV is hereby created to read: CSB 2.012 Note(km) Prazepam
CSB 2.012 HistoryHistory: Cr. Register, November, 1977, No. 263, eff. 12-1-77. CSB 2.012 NoteCSB 2.15 Addition of parahexyl to schedule I; removal of loperamide from schedule V; addition of triazolam to schedule IV. (1) Paragraph (mn) of sub. (4), s. 161.14, Stats., is created to read: CSB 2.012 Note(mn) Parahexyl
CSB 2.012 Note(2) Paragraph (a) of sub. (3), s. 161.22, Stats., is repealed.
CSB 2.012 Note(3) Paragraph (nm) of sub. (2), s. 161.20, Stats., is created to read: CSB 2.012 Note(nm) Triazolam
CSB 2.012 HistoryHistory: Cr. Register, October, 1984, No. 346, eff. 11-1-84. CSB 2.012 NoteCSB 2.16 Transfer of sufentanil from schedule I to schedule II. (1) Section 161.14 (2) (xg), Stats., is repealed.
CSB 2.012 Note(y) Sufentanil
CSB 2.012 HistoryHistory: Cr. Register, October, 1984, No. 346, eff. 11-1-84. CSB 2.012 NoteCSB 2.17 Addition of buprenorphine to schedule V; transfer of methaqualone from schedule II to schedule I; transfer of dronabinol from schedule I to schedule II. (2) Paragraph (b) of s. 161.14 (5), Stats., is adopted to read: CSB 2.012 Note(b) Methaqualone
CSB 2.012 Note(3) Subsection (7) (am) of s. 161.16, Stats., is repealed.
CSB 2.012 Note(4) Subsection (10) (a) of s. 161.16, Stats., is created to read: CSB 2.012 Note(10) Hallucinogenic substances. (a) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. food and drug administration approved drug product. (Other names for dronabinol are (6a R - trans) - 6a, 7, 8, 10a - tetrahydro - 6, 6, 9 - trimethyl - 3 -pentyl-6H-dibenzo (b, d) pyran - 1 - ol, or (-) - delta - 9 - (trans) - tetrahydrocannabinol.)
CSB 2.012 NoteCSB 2.18 Addition of 3,4-methylenedioxymethamphetamine to schedule I. Paragraph (am) of s. 161.14 (4), Stats., is created to read: CSB 2.012 Note(am) 3, 4-methylenedioxymethamphetamine, commonly known as“MDMA”;
CSB 2.012 HistoryHistory: Cr. Register, September, 1987, No. 381, eff. 10-1-87. CSB 2.012 NoteCSB 2.19 Additions, deletions and transfers to statutory schedules. (1) Paragraph (b) of s. 161.20 (4), Stats., is created to read: CSB 2.012 Note(b) Not more than 25 milligrams per dosage unit of pentazocine with one or more active, non-narcotic ingredients in recognized therapeutic amounts.
CSB 2.012 Note(2) Paragraph (b) of s. 161.18 (4), Stats., is repealed.
CSB 2.012 Note(3) Paragraph (km) of s. 161.20 (2), Stats., is renumbered to read:
CSB 2.012 Note(mg) Prazepam;
CSB 2.012 Note(4) Paragraph (hg) of s. 161.20 (2), Stats., is created to read: CSB 2.012 Note(hg) Midazolam;
CSB 2.012 Note(5) Paragraph (mm) of s. 161.20 (2), Stats., is created to read: CSB 2.012 Note(mm) Quazepam;
CSB 2.012 Note(6) Paragraph (km) of s. 161.18 (3), Stats., is created to read: CSB 2.012 Note(km) Tiletamine and Zolazepam or any salt thereof;
CSB 2.012 Note(7) Paragraph (a) of s. 161.16 (3), Stats., is renumbered to read:
CSB 2.012 Note(am) Alphaprodine;
CSB 2.012 Note(8) Paragraph (a) of s. 161.16 (3), Stats., is created to read: CSB 2.012 Note(a) Alfentanil;
CSB 2.012 Note(9) Paragraph (rg) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(rg) MPPP 1-methyl-4-phenyl-4-propionoxypiperidine);
CSB 2.012 Note(10) Paragraph (vg) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(vg) (PEPAP) 1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine;
CSB 2.012 Note(11) Paragraph (b) of s. 161.16 (10), Stats., is created to read: CSB 2.012 Note(b) Nabilone (another name for nabilone: (+)-trans-3- (1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1- hydroxy-6, 6-dimethyl-9H-dibenzo [b,d] pyran-9-one).
CSB 2.012 Note(12) Subsection (2) of s. 161.14, Stats., is amended to read: CSB 2.012 Note(2) Opiates. Unless specifically excepted under federal regulations or unless listed in another schedule, any of the following opiates, or their isomers, esters, ethers, salts, salts of isomers, esters of ethers, if isomers, esters, ethers, salts or salts of isomers exist within the specified chemical designation (for purposes of par. (tg) only, the term isomer includes the optical and geometric isomers):
CSB 2.012 Note(13) Paragraph (a) of s. 161.14 (2), Stats., is renumbered to read:
CSB 2.012 Note(ag) Acetylmethadol;
CSB 2.012 Note(14) Paragraph (a) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(a) Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
CSB 2.012 Note(15) Paragraph (cg) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(cg) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.012 Note(16) Paragraph (dg) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(dg) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl) -4-piperidinyl]-N-phenylpropanamide);
CSB 2.012 Note(17) Paragraph (rj) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(rj) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl) ethyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.012 Note(18) Paragraph (tg) of s. 161.14 (2), Stats., is created to read: CSB 2.012 Note(tg) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1- (2-phenethyl)-4-piperidinyl]propanamide);
CSB 2.012 Note(19) Paragraph (xm) of s. 161.14 (2), Stats., is created to read:
